Interferon gamma can play an anti-cancer role in pancreatic cancer by mediating the CXCL8-CXCR2 axis and CD8 + T-lymphocytes to participate in the regulation of the PD1 signaling pathway 55, 56. This evidence concerns the gene IFNG and familial pancreatic carcinoma.